Business

Glenmark Pharmaceuticals has announced the launch of its Tiogiva tiotropium bromide DPI in the UK for the treatment of COPD. The company announced in August 2018 that it had acquired the rights to market the generic version of Spiriva Handihaler in Western Europe; the company also acquired the rights to market the Stalpex fluticasone/salmeterol DPI in Europe from … [Read more...] about Glenmark launches Tiogiva tiotropium DPI in the UK

Taiba Middle East announced that it has acquired exclusive distribution and marketing rights to Insmed's Arikayce amikacin liposome inhalation suspension in Saudi Arabia, UAE, Kuwait, Oman, Qatar, and Bahrain, the six countries that make up the Gulf Cooperation Council. In the US, Arikayce has been approved for the treatment of nontuberculous mycobacterial (NTM) … [Read more...] about Taiba gets rights to Arikayce in Gulf Cooperation Council countries

MannKind Corporation will develop a dry powder formulation of Thirona Bio's FBM5712 ALK-5 kinase inhibitor, the companies have announced. The deal gives MannKind the option to license the compound for the treatment of fibrotic diseases in the lung and includes "a convertible promissory note purchase agreement to support Thirona’s Series A financing." ALK-5 kinase … [Read more...] about MannKind partners with Thirona on inhaled ALK-5 kinase inhibitor

Nuance Pharma will pay $25 million in cash, plus equity in its parent company Nuance Biotech valued at $15 million, as well as potential milestone payments worth up to $179 million to Verona Pharma for the rights to develop and market Verona's ensifentrine inhaled PDE3/PDE4 inhibitor in mainland China, Taiwan, Hong Kong and Macau. According to the announcement, Nuance … [Read more...] about Nuance Pharma acquires Chinese rights to Verona’s ensifentrine

Nuformix said that it has received a Notice of Allowance for US Patent Application No. 17/051,592 titled, "Crystalline Tranilast Salts and Their Pharmaceutical Use." The company has already been granted one patent covering crystalline forms of tranilast. According to Nuformix, pre-clinical studies of its NXP002 tranilast, which it is developing as a potential inhaled … [Read more...] about Nuformix gets notice of allowance for US patent covering its inhaled tranilast

Lupin has announced the US launch of an authorized generic version of Sunovion's Brovana arformoterol tartrate inhalation solution for the treatment of COPD. The FDA tentatively approved the company's ANDA for the inhalation solution in April 2020. The FDA approved Brovana for the treatment of COPD in 2006, requiring a post-marketing safety study. In 2013, … [Read more...] about Lupin launches authorized generic of Brovana inhalation solution in the US

Evoke Pharma said that the United States Patent and Trademark Office (USPTO) has issued US patent No. 11,020,361 ("Nasal Formulations of Metoclopramide”) covering methods of use for Gimoti metoclopramide nasal spray for the treatment of gastroparesis until at least 2029. The FDA approved Gimoti for the treatment of diabetic gastroparesis in June 2020. Evoke … [Read more...] about Evoke gets new US patent for Gimoti nasal spray